Press Release Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald 6 hours ago
Press Release Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates Aug 17
Press Release Eikon Therapeutics Announces Seven Abstracts Accepted for Presentation at the 2026 European Society of Medical Oncology (ESMO) Congress Jul 20